Srivastava G - Search Results

1

Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G, Halpern B, Zhang S, Chen J, Bunck MC, Ahmad NN, Forrester T. Wadden TA, et al. Among authors: srivastava g. Nat Med. 2024 Feb 27. doi: 10.1038/s41591-024-02883-1. Online ahead of print. Nat Med. 2024. PMID: 38409593 No abstract available.

2

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G, Halpern B, Zhang S, Chen J, Bunck MC, Ahmad NN, Forrester T. Wadden TA, et al. Among authors: srivastava g. Nat Med. 2023 Nov;29(11):2909-2918. doi: 10.1038/s41591-023-02597-w. Epub 2023 Oct 15. Nat Med. 2023. PMID: 37840095 Free PMC article. Clinical Trial.

3

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

Srivastava G, Kumar RB. Srivastava G, et al. N Engl J Med. 2021 Jul 1;385(1):e4. doi: 10.1056/NEJMc2106918. N Engl J Med. 2021. PMID: 34192449 No abstract available.

4

Specialized Medical Weight Management Intervention for High-Risk Obesity.

Srivastava G, Paris C, Johnson J, Barnes E, Cunningham BL, Stimson CJ, Niswender KD, Poon SJ. Srivastava G, et al. J Health Econ Outcomes Res. 2021 Jul 1;8(2):1-5. doi: 10.36469/001c.24896. eCollection 2021. J Health Econ Outcomes Res. 2021. PMID: 34250178 Free PMC article.

5

Metaflammation in obesity and its therapeutic targeting.

Schleh MW, Caslin HL, Garcia JN, Mashayekhi M, Srivastava G, Bradley AB, Hasty AH. Schleh MW, et al. Among authors: srivastava g. Sci Transl Med. 2023 Nov 22;15(723):eadf9382. doi: 10.1126/scitranslmed.adf9382. Epub 2023 Nov 22. Sci Transl Med. 2023. PMID: 37992150 Free PMC article. Review.

6

Obesity Management in Children and Adolescents.

Wong G, Srivastava G. Wong G, et al. Among authors: srivastava g. Gastroenterol Clin North Am. 2023 Jun;52(2):443-455. doi: 10.1016/j.gtc.2023.03.011. Epub 2023 Apr 7. Gastroenterol Clin North Am. 2023. PMID: 37197885 Review.

7

High Prevalence of Positive Genetic Obesity Variants in Postoperative Bariatric Surgery Patients with Weight Regain Presenting for Medical Obesity Intervention.

Samuels JM, Paddu NU, Rekulapeli A, Madhar A, Srivastava G. Samuels JM, et al. Among authors: srivastava g. Obes Surg. 2024 Jan;34(1):170-175. doi: 10.1007/s11695-023-06952-1. Epub 2023 Nov 23. Obes Surg. 2024. PMID: 37996769

8

Current pharmacotherapy for obesity.

Srivastava G, Apovian CM. Srivastava G, et al. Nat Rev Endocrinol. 2018 Jan;14(1):12-24. doi: 10.1038/nrendo.2017.122. Epub 2017 Oct 13. Nat Rev Endocrinol. 2018. PMID: 29027993 Review.

9

Prevalence of genetic causes of obesity in clinical practice.

Tamaroff J, Williamson D, Slaughter JC, Xu M, Srivastava G, Shoemaker AH. Tamaroff J, et al. Among authors: srivastava g. Obes Sci Pract. 2023 May 26;9(5):508-515. doi: 10.1002/osp4.671. eCollection 2023 Oct. Obes Sci Pract. 2023. PMID: 37810530 Free PMC article.

10

Diagnostic challenge: A pediatric patient with severe obesity and complications of imminent death.

Srivastava G. Srivastava G. Obes Pillars. 2023 Jun 25;7:100077. doi: 10.1016/j.obpill.2023.100077. eCollection 2023 Sep. Obes Pillars. 2023. PMID: 37990678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page